Eosinophilic Esophagitis
182
26
39
98
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
40 trials with published results (22%)
Research Maturity
98 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
7.7%
14 terminated out of 182 trials
87.5%
+0.9% vs benchmark
13%
23 trials in Phase 3/4
41%
40 of 98 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 98 completed trials
Clinical Trials (182)
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Capsule Sponge Study in Eosinophilic Oesophagitis
Characteristics and Inflammatory Markers in Children With Eosinophilic Esophagitis (EoE)
Natural History and Genetics of Food Allergy and Related Conditions
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
Risk Factors and Biomarkers for Diagnosis and Treatment of EoE
Indiana University Gastrointestinal Motility Diagnosis Registry
Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic Esophagitis
A Prospective Study of the Four Food Elimination Diet for Treatment of Eosinophilic Esophagitis
Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
Cow's Milk Elimination for Treatment of Eosinophilic Esophagitis
Prospective Database for Eosinophilic Esophagitis (EoE) of Pediatric Population
Comparing the Availability of AQ280 in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation
A Study of CDX-0159 in Patients With Eosinophilic Esophagitis
A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis
Esophageal String Test in Eosinophilic Esophagitis
A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis